Co-diagnostics jv cosara receives clearance from indian fda for covid-19 2-gene multiplex test

Salt lake city, nov. 25, 2020 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that cosara diagnostics pvt ltd ("cosara," or the "jv"),...
CODX Ratings Summary
CODX Quant Ranking